Occupe actuellement des postes chez FibroGen Inc and Intra-Cellular Therapies Inc
Position | Company | Period |
---|---|---|
Independent Director | FibroGen Inc | 1 octobre 1993 - |
Independent Director | Intra-Cellular Therapies Inc | 1 janvier 2014 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2023-12-14 | 2023-12-12 |
Calyxt Inc
(CLXT)
|
A Achat |
517 107
+46.8%
10,585 470 992 USD |
517 107 +46.8% | 10,58 | 5 470 992 USD | |
2023-06-02 | 2023-06-01 |
Calyxt Inc
(CLXT)
|
A Achat |
1 000
+0.1%
31,5031 500 USD |
1 000 +0.1% | 31,50 | 31 500 USD | |
2023-05-22 | 2023-05-22 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
1 750 000
-99.6%
32,8257 435 000 USD |
1 750 000 -99.6% | 32,82 | 57 435 000 USD | |
2023-03-30 | 2023-03-30 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
130 024
-8.2%
36,264 714 345 USD |
130 024 -8.2% | 36,26 | 4 714 345 USD | |
2023-03-30 | 2023-03-29 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
9 926
-0.6%
36,95366 766 USD |
9 926 -0.6% | 36,95 | 366 766 USD | |
2022-12-13 | 2022-12-09 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
19 990
-12.8%
42,07840 939 USD |
19 990 -12.8% | 42,07 | 840 939 USD | |
2022-11-21 | 2022-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
120 000
-43.4%
42,335 079 924 USD |
120 000 -43.4% | 42,33 | 5 079 924 USD | |
2022-09-15 | 2022-09-15 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
52 025
-15.8%
42,212 195 960 USD |
52 025 -15.8% | 42,21 | 2 195 960 USD | |
2022-09-15 | 2022-09-14 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
47 975
-12.7%
42,412 034 428 USD |
47 975 -12.7% | 42,41 | 2 034 428 USD | |
2022-08-11 | 2022-08-09 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
45 000
-10.7%
43,731 967 823 USD |
45 000 -10.7% | 43,73 | 1 967 823 USD | |
2022-05-23 | 2022-05-20 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
123 696
-21.5%
39,284 858 655 USD |
123 696 -21.5% | 39,28 | 4 858 655 USD | |
2022-05-23 | 2022-05-19 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
26 304
-4.4%
40,091 054 651 USD |
26 304 -4.4% | 40,09 | 1 054 651 USD | |
2022-03-30 | 2022-03-29 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
60 000
-9.1%
38,592 315 322 USD |
60 000 -9.1% | 38,59 | 2 315 322 USD | |
2022-03-21 | 2022-03-21 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
14 322
-100.0%
39,05559 288 USD |
14 322 -100.0% | 39,05 | 559 288 USD | |
2022-03-21 | 2022-03-21 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
25 545
-100.0%
39,05997 558 USD |
25 545 -100.0% | 39,05 | 997 558 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
56 181
-39.7%
39,772 234 094 USD |
56 181 -39.7% | 39,77 | 2 234 094 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
26 238
-64.7%
39,381 033 334 USD |
26 238 -64.7% | 39,38 | 1 033 334 USD | |
2022-03-21 | 2022-03-18 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
46 803
-64.7%
39,381 843 247 USD |
46 803 -64.7% | 39,38 | 1 843 247 USD | |
2022-03-18 | 2022-03-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
15 736
-100.0%
61,35965 352 USD |
15 736 -100.0% | 61,35 | 965 352 USD | |
2022-03-18 | 2022-03-18 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
4 901
-23.7%
60,63297 154 USD |
4 901 -23.7% | 60,63 | 297 154 USD | |
2022-03-18 | 2022-03-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
114 912
-84.8%
60,416 941 570 USD |
114 912 -84.8% | 60,41 | 6 941 570 USD | |
2022-03-18 | 2022-03-17 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
26 587
-16.4%
59,991 595 076 USD |
26 587 -16.4% | 59,99 | 1 595 076 USD | |
2022-03-18 | 2022-03-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
43 848
-21.3%
59,532 610 057 USD |
43 848 -21.3% | 59,53 | 2 610 057 USD | |
2022-03-18 | 2022-03-16 |
Intra-Cellular Therapies Inc
(ITCI)
|
V Vente |
20 686
-9.1%
58,721 214 771 USD |
20 686 -9.1% | 58,72 | 1 214 771 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
31 341
-2.7%
42,331 326 636 USD |
31 341 -2.7% | 42,33 | 1 326 636 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
38 815
-2.1%
42,351 643 749 USD |
38 815 -2.1% | 42,35 | 1 643 749 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
69 233
-12.2%
42,352 931 900 USD |
69 233 -12.2% | 42,35 | 2 931 900 USD | |
2021-11-18 | 2021-11-17 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
62 435
-9.1%
42,392 646 401 USD |
62 435 -9.1% | 42,39 | 2 646 401 USD | |
2021-11-18 | 2021-11-16 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
12 565
-1.8%
42,01527 805 USD |
12 565 -1.8% | 42,01 | 527 805 USD | |
2021-06-29 | 2021-06-29 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
479 800
-12.2%
41,2619 794 437 USD |
479 800 -12.2% | 41,26 | 19 794 437 USD | |
2021-06-29 | 2021-06-29 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
1 200
-0.0%
42,0150 409 USD |
1 200 -0.0% | 42,01 | 50 409 USD | |
2021-06-29 | 2021-06-28 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
167 448
-4.1%
42,117 051 269 USD |
167 448 -4.1% | 42,11 | 7 051 269 USD | |
2021-06-29 | 2021-06-25 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
487 364
-10.6%
42,6920 807 519 USD |
487 364 -10.6% | 42,69 | 20 807 519 USD | |
2021-06-29 | 2021-06-25 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
179 100
-16.1%
42,817 666 501 USD |
179 100 -16.1% | 42,81 | 7 666 501 USD | |
2020-10-22 | 2020-10-20 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
463 200
-100.0%
42,0019 454 400 USD |
463 200 -100.0% | 42,00 | 19 454 400 USD | |
2020-06-23 | 2020-06-18 |
Royalty Pharma PLC
(RPRX)
|
A Achat |
15 000
+inf%
28,00420 000 USD |
15 000 +inf% | 28,00 | 420 000 USD | |
2022-12-13 | 2002-12-12 |
Royalty Pharma PLC
(RPRX)
|
V Vente |
40 010
-29.3%
41,981 679 684 USD |
40 010 -29.3% | 41,98 | 1 679 684 USD |